Faculty News
Nanomedicine Researcher Fanfei Meng Joins PPS Department
September 29 – The 91ÆÆ½â°æ College of Pharmacy welcomes Fanfei Meng, Ph.D., as an assistant professor and Presidential Frontier Faculty in the Department of Pharmacological and Pharmaceutical Sciences.
Meng arrives at from the University of Massachusetts Lowell, where he served as
an assistant professor in the Department of Biomedical and Nutritional Sciences and
a member of the University of Massachusetts Cancer Center. He previously completed
postdoctoral training in immunoengineering at Purdue University, where he also earned
his joint Ph.D. in Pharmaceutical Engineering in collaboration with China Pharmaceutical
University.
Meng’s research is at the forefront of nanomedicine and immunotherapy, with a focus on developing nucleic acid-based therapeutics, engineering immunostimulatory drug carriers, and advancing nanomedicine platforms for cancer, sepsis, and metabolic disease treatments. His innovative contributions include leading studies on lipid nanoparticles (LNPs) for mRNA delivery, novel immunoactivity nanocomplexes for tumor immunotherapy, and the development of nanomedicine strategies that overcome resistance in immune-cold tumors.
Meng has authored more than 25 peer-reviewed publications in such journals as Proceedings of the National Academy of Sciences, ACS Nano, Nano Letters, Biomaterials, and the Journal of Controlled Release. He is also credited as an inventor on multiple patents and invention disclosures in cancer nanomedicine and drug delivery technologies.
Meng’s work has been recognized with numerous honors, including the American Association of Gene and Cell Therapy Travel Award (2023), the American Association of Pharmaceutical Scientists Best Abstract Award (2022), and the Controlled Release Society Best Poster Award (2023). His leadership in the field extends to service as president of the Purdue Postdoctoral Association, National Institutes of Health ad-hoc panelist, and reviewer for such journals as the Journal of Nanobiotechnology, Journal of Controlled Release, ACS Applied Materials & Interfaces, and Advanced Therapeutics.
—&²Ô²ú²õ±è;Naqiyah Kantawala